Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:50 UTC
  • 2
  • 1 comments

Grindr nomina tre nuovi direttori nel suo consiglio di amministrazione

Market reaction Comment Full text

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:50 UTC
  • 1
  • 1 comments

Společnost Grindr nominuje tři nové členy do svého představenstva

Market reaction Comment Full text

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:50 UTC
  • 3
  • 1 comments

A Grindr indica três novos diretores para seu Conselho de Administração

Market reaction Comment Full text

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:50 UTC
  • 2
  • 1 comments

Grindr propose la candidature de trois nouveaux administrateurs à son conseil d’administration

Market reaction Comment Full text

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:50 UTC
  • 2
  • 1 comments

Grindr przedstawia trzech nowych kandydatów na członków zarządu

Market reaction Comment Full text

BITDEER TECHNOLOGIES GROUP (BTDR)

  • Business News
  • May 01, 2026, 16:50 UTC
  • 2
  • 1 comments

Bitdeer Announces First Quarter 2026 Earnings Conference Call for May 14th 2026

Market reaction Comment Full text

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:50 UTC
  • 3
  • 1 comments

Grindr nominó tres nuevos miembros para su Consejo de Administración

Market reaction Comment Full text

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:50 UTC
  • 3
  • 1 comments

Grindr nomineert drie nieuwe bestuursleden voor zijn Raad van Bestuur

Market reaction Comment Full text

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:49 UTC
  • 3
  • 1 comments

Grindr stellt drei neue Kandidaten fürs Board of Directors vor

Market reaction Comment Full text

ARVINAS, INC. (ARVN)

  • Business News
  • May 01, 2026, 16:43 UTC
  • 2
  • 1 comments

Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

Market reaction Comment Full text
  • Previous
  • 200
  • 201
  • 202
  • 203
  • 204
  • Next

Search

News categories

  • Technical Exchange News(12315)
  • Event(6229)
  • SEC News(267665)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155803)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin